OIG: Medicaid Drug Rebate Collections Uneven
The audit found that 36 of 49 states that responded to OIG's query reported collecting rebates on single-source physician-administered drugs, and 20 multiple-source, physician-administered drugs with the highest dollar value. An additional 12 states reported collecting rebates but were not in full compliance with federal requirements.
OIG last conducted an audit of states' efforts to collect Medicaid drug rebates in 2001, and found at that time that only 17 states had done so, and that most states reported at the time that they had no way of determining which drugmaker was responsible for which rebates.
That prompted the federal government in 2005 to require states to collect the rebates or risk losing matching federal funds. To help, the federal government created national drug codes that identified a drug's manufacturer.
- Sharp HealthCare Leaves Pioneer ACO Program
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Acute Kidney Injury Gets New Focus
- MA an Insurance Proving Ground for Providers
- Targeting Self-Insured Populations
- States Without Medicaid Expansion Search for Alternatives
- 'Kafkaesque' Value System Unfairly Penalizes Doctor Pay
- mHealth Tackles Readmissions
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- Interventional Radiology No Longer a Sub-Specialty